$NVOS
Novo Integrated Sciences, Inc. Stock $nvos

$nvos Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222019313 Filed on July 14, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$11.74M	$13.85M	$2.869M
YoY Change	335.89%	481.77%	37.94%
Cost Of Revenue	$6.939M	$11.44M	$1.653M
YoY Change	305.0%	939.79%	25.22%
Gross Profit	$4.799M	$2.409M	$1.216M
YoY Change	389.9%	88.13%	62.18%
Gross Profit Margin	40.89%	17.39%	42.39%
Selling, General & Admin	$14.39M	$3.612M	$3.337M
YoY Change	419.67%	114.67%	60.43%
% of Gross Profit	299.74%	149.93%	274.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$669.8K	$881.6K	$773.6K
YoY Change	10.68%	132.65%	103.57%
% of Gross Profit	13.96%	36.6%	63.6%
Operating Expenses	$14.39M	$3.612M	$3.337M
YoY Change	419.67%	114.67%	60.43%
Operating Profit	-$9.586M	-$1.203M	-$2.121M
YoY Change	435.98%	199.21%	59.45%
Interest Expense	-$8.041M	$513.4K	-$2.748M
YoY Change	10481.41%	2265.78%	27375.2%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$2.541M	-$2.748M
YoY Change		19008.8%
Pretax Income	-$33.07M	-$3.744M	-$4.868M
YoY Change	1602.78%	801.59%	263.3%
Income Tax	-$22.30K
% Of Pretax Income
Net Earnings	-$32.85M	-$3.810M	-$4.868M
YoY Change	1593.59%	826.6%	263.14%
Net Earnings / Revenue	-279.86%	-27.51%	-169.67%
Basic Earnings Per Share		-$0.13	-$0.17
Diluted Earnings Per Share	-$1.13	-$127.8K	-$167.2K
COMMON SHARES
Basic Shares Outstanding	31.02M shares	29.82M shares	28.74M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.179M	$12.68M	$15.94M
YoY Change	-73.73%	51.52%	837.88%
Cash & Equivalents	$2.179M	$12.68M	$15.94M
Short-Term Investments
Other Short-Term Assets	$571.3K	$380.8K	$503.4K
YoY Change	161.63%	4.83%	19.87%
Inventory	$879.0K	$645.1K	$334.4K
Prepaid Expenses
Receivables	$1.017M	$5.166M	$1.252M
Other Receivables	$1.085M	$1.209M	$981.6K
Total Short-Term Assets	$5.732M	$20.08M	$19.02M
YoY Change	-48.52%	85.37%	428.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.801M	$5.932M	$8.506M
YoY Change	-4.44%	92.02%	195.35%
Goodwill	$7.826M	$11.37M
YoY Change	-17.53%
Intangibles	$18.84M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$35.14M	$51.71M	$51.30M
YoY Change	-30.86%	64.72%	64.12%
TOTAL ASSETS
Total Short-Term Assets	$5.732M	$20.08M	$19.02M
Total Long-Term Assets	$35.14M	$51.71M	$51.30M
Total Assets	$40.87M	$71.79M	$70.32M
YoY Change	-34.03%	70.01%	101.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.800M	$1.622M	$1.106M
YoY Change	24.17%	90.95%	22.86%
Accrued Expenses	$1.116M	$1.244M	$2.336M
YoY Change	-1.17%	9.73%	88.42%
Deferred Revenue	$36.89K
YoY Change	-4.51%
Short-Term Debt	$9.579M	$2.332M	$2.046M
YoY Change	1900.03%	509.6%	278.86%
Long-Term Debt Due	$8.890K	$5.276M	$5.278M
YoY Change	-99.8%	372.47%	444.08%
Total Short-Term Liabilities	$14.07M	$12.73M	$11.55M
YoY Change	66.29%	261.29%	215.68%
LONG-TERM LIABILITIES
Long-Term Debt	$1.120M	$11.40M	$10.89M
YoY Change	-81.74%	28732.98%
Other Long-Term Liabilities	$2.185M	$1.735M	$1.867M
YoY Change	6.2%	-15.55%	-9.38%
Total Long-Term Liabilities	$3.305M	$13.14M	$12.75M
YoY Change	-59.64%	527.34%	519.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.07M	$12.73M	$11.55M
Total Long-Term Liabilities	$3.305M	$13.14M	$12.75M
Total Liabilities	$18.83M	$27.36M	$25.77M
YoY Change	3.7%	392.46%	354.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$53.82M	-$31.39M
YoY Change	156.65%
Common Stock	$31.18K	$30.66K
YoY Change	17.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$22.31M	$44.37M	$44.55M
YoY Change
Total Liabilities & Shareholders Equity	$40.87M	$71.79M	$70.32M
YoY Change	-34.03%	70.01%	101.72%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$32.85M	-$3.810M	-$4.868M
YoY Change	1593.59%	826.6%	263.14%
Depreciation, Depletion And Amortization	$669.8K	$881.6K	$773.6K
YoY Change	10.68%	132.65%	103.57%
Cash From Operating Activities	$675.8K	-$3.550M	-$2.251M
YoY Change	-190.64%	-2455.48%	703.8%
INVESTING ACTIVITIES
Capital Expenditures	-$800.00		-$72.14K
YoY Change	-98.53%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$324.3K	$0.00
YoY Change	-100.0%	-167.57%
Cash From Investing Activities	$810.00	$325.9K	-$72.14K
YoY Change	-99.98%	-147.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.23M	-37.24K	9.440M
YoY Change	294.69%	-100.52%	-47299.65%
NET CHANGE
Cash From Operating Activities	675.8K	-3.550M	-2.251M
Cash From Investing Activities	810.0	325.9K	-72.14K
Cash From Financing Activities	-11.23M	-37.24K	9.440M
Net Change In Cash	-10.55M	-3.262M	7.117M
YoY Change	-11849.09%	-149.33%	-2472.39%
FREE CASH FLOW
Cash From Operating Activities	$675.8K	-$3.550M	-$2.251M
Capital Expenditures	-$800.00		-$72.14K
Free Cash Flow	$676.6K	-$3.550M	-$2.178M
YoY Change	-197.92%	6995.96%	678.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	NVOS	Payment On Other Receivable PaymentOnOtherReceivable		usd
	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable		usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2021Q1	NVOS	Stock Issued During Period Value Stock Splits StockIssuedDuringPeriodValueStockSplits		usd
	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001138978
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--08-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q2	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
CY2021Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2021Q3	NVOS	Contingent Liabilities Current ContingentLiabilitiesCurrent		usd
CY2021Q3	NVOS	Convertible Notes Payable Net Of Discount ConvertibleNotesPayableNetOfDiscount		usd
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2021Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2021Q4	NVOS	Common Stock Issued To Be Held In Escrow CommonStockIssuedToBeHeldInEscrow		usd
	NVOS	Repayments Of Finance Leases RepaymentsOfFinanceLeases		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	NVOS	Common Stock Issued For Acquisition Of Assets CommonStockIssuedForAcquisitionOfAssets		usd
	NVOS	Conversion Of Convertible Notes Payable And Accrued Interest To Common Stock ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock		usd
CY2022Q2	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2021Q3	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross		usd
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-05-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40089
	dei	Entity Registrant Name EntityRegistrantName	Novo Integrated Sciences, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	59-3691650
	dei	Entity Address Address Line1 EntityAddressAddressLine1	11120 NE 2nd Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
	dei	Entity Address City Or Town EntityAddressCityOrTown	Bellevue
	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98004
	dei	City Area Code CityAreaCode	(206)
	dei	Local Phone Number LocalPhoneNumber	617-9797
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	NVOS
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	31021645	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12677446	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8293162	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5166239	usd
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1468429	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	645063	usd
CY2021Q3	us-gaap	Inventory Net InventoryNet	339385	usd
CY2022Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1209137	usd
CY2021Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	814157	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	380800	usd
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	218376	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	20078685	usd
CY2021Q3	us-gaap	Assets Current AssetsCurrent	11133509	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5931683	usd
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6070291	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	32192858	usd
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	32029499	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2222970	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2543396	usd
CY2021Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	692738	usd
CY2022Q2	us-gaap	Goodwill Goodwill	11366618	usd
CY2021Q3	us-gaap	Goodwill Goodwill	9488848	usd
CY2022Q2	us-gaap	Assets Assets	71792814	usd
CY2021Q3	us-gaap	Assets Assets	61958281	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1621719	usd
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1449784	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1243792	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1129309	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	961823	usd
CY2021Q3	us-gaap	Interest Payable Current InterestPayableCurrent	366280	usd
CY2022Q2	NVOS	Notes And Loan Payable Current NotesAndLoanPayableCurrent	5260056	usd
CY2021Q3	NVOS	Notes And Loan Payable Current NotesAndLoanPayableCurrent	4485649	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1875000	usd
CY2022Q2	NVOS	Contingent Liabilities Current ContingentLiabilitiesCurrent	750860	usd
CY2022Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	456528	usd
CY2021Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	478920	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	15982	usd
CY2021Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	23184	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	544690	usd
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	530797	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	12730450	usd
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8463923	usd
CY2022Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	981337	usd
CY2021Q3	us-gaap	Secured Long Term Debt SecuredLongTermDebt	982205	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	158645	usd
CY2021Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	5133604	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	5170205	usd
CY2022Q2	NVOS	Convertible Notes Payable Net Of Discount ConvertibleNotesPayableNetOfDiscount	10252017	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	8563	usd
CY2021Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	16217	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1734790	usd
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2057805	usd
CY2022Q2	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	1499045	usd
CY2021Q3	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	1500372	usd
CY2022Q2	us-gaap	Liabilities Liabilities	27364847	usd
CY2021Q3	us-gaap	Liabilities Liabilities	18154126	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30659073	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30659073	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26610144	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26610144	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	30659	usd
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	26610	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	64620878	usd
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54579396	usd
CY2022Q2	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	4308591	shares
CY2021Q3	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	3622199	shares
CY2022Q2	NVOS	Common Stock Subscribed But Unissued Subscriptions Receivable CommonStockSubscribedButUnissuedSubscriptionsReceivable	10096332	usd
CY2021Q3	NVOS	Common Stock Subscribed But Unissued Subscriptions Receivable CommonStockSubscribedButUnissuedSubscriptionsReceivable	9236607	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1015993	usd
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	991077	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31391082	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20969274	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	44372780	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	43864416	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	55187	usd
CY2021Q3	us-gaap	Minority Interest MinorityInterest	-60261	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	44427967	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	43804155	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	71792814	usd
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	61958281	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13851883	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2380974	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19883033	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6612374	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	11443001	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	1100516	usd
	us-gaap	Cost Of Revenue CostOfRevenue	14991331	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3769020	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	2408882	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	1280458	usd
	us-gaap	Gross Profit GrossProfit	4891702	usd
	us-gaap	Gross Profit GrossProfit	2843354	usd
CY2022Q2	us-gaap	Selling Expense SellingExpense	9802	usd
CY2021Q2	us-gaap	Selling Expense SellingExpense	2381	usd
	us-gaap	Selling Expense SellingExpense	36340	usd
	us-gaap	Selling Expense SellingExpense	4226	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3601826	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1680049	usd
	us-gaap	Profit Loss ProfitLoss	-10428624	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10421808	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9542443	usd
	us-gaap	Profit Loss ProfitLoss	-2528965	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2522527	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-3744025	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5324768	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	3611628	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	1682430	usd
	us-gaap	Operating Expenses OperatingExpenses	9578783	usd
	us-gaap	Operating Expenses OperatingExpenses	5328994	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1202746	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-401972	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4687081	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2485640	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	8355	usd
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	8402	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	25233	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	25265	usd
CY2022Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	513398	usd
CY2021Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	21701	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1808310	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	68590	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2133890	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3654752	usd
CY2022Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	97654	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-303714	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2541279	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13299	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5741543	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-43325	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3744025	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-415271	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10428624	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2528965	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-3744025	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-415271	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	66029	usd
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-4084	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-6816	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-6438	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-3810054	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-411187	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-415271	usd
	us-gaap	Profit Loss ProfitLoss	-10428624	usd
	us-gaap	Profit Loss ProfitLoss	-2528965	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	13711	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	123521	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	24916	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	176349	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3730314	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-291750	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10403708	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2352616	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29817999	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25298866	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28498414	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24192998	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	43804155	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	64750	usd
CY2021Q4	NVOS	Stock Issued During Period Value Purchase Of Asset StockIssuedDuringPeriodValuePurchaseOfAsset	1081236	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	188925	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	295824	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	154135	usd
CY2021Q4	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	-104388	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-1816395	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	43668242	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	298000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5257466	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	44427	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	115093	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-4868204	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	44515024	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	314000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1247849	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1704000	usd
CY2022Q2	NVOS	Common Stock To Be Issued For Acquisitions CommonStockToBeIssuedForAcquisitions	286027	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	91330	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	13762	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-3744025	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	44427967	usd
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29571630	usd
CY2020Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	92000	usd
CY2020Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	248000	usd
CY2020Q4	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	10371	usd
CY2020Q4	us-gaap	Profit Loss ProfitLoss	-773103	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29148898	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12000	usd
CY2021Q1	NVOS	Common Stock Issued For Intellectual Property CommonStockIssuedForIntellectualProperty	876000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	375000	usd
CY2021Q1	NVOS	Fair Value Of Vested Stock Options FairValueOfVestedStockOptions	22215	usd
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	41267	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-1340591	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29134789	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	430837	usd
CY2021Q2	NVOS	Common Stock To Be Issued For Services Rendered CommonStockToBeIssuedForServicesRendered	37172	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7235580	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket	66640	usd
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest	120378	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-415271	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	36610125	usd
	us-gaap	Profit Loss ProfitLoss	-10428624	usd
	us-gaap	Profit Loss ProfitLoss	-2528965	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2349434	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1118925	usd
	NVOS	Fair Value Of Vested Stock Options FairValueOfVestedStockOptions	-289892	usd
	NVOS	Fair Value Of Vested Stock Options FairValueOfVestedStockOptions	-88855	usd
	NVOS	Common Stock Issued For Services CommonStockIssuedForServices	676750	usd
	NVOS	Common Stock Issued For Services CommonStockIssuedForServices	660172	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	418188	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	467864	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3654752	usd
	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	303714	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3650069	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-543213	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	263539	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	150632	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	143590	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	117056	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-97659	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-68871	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	64513	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	598904	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	7455	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-406862	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-460063	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6559907	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-279280	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	190973	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	201369	usd
	NVOS	Payments For Proceeds Cash From Acquisition PaymentsForProceedsCashFromAcquisition	57489	usd
	NVOS	Payments For Proceeds Cash From Acquisition PaymentsForProceedsCashFromAcquisition	-10000	usd
	NVOS	Payment On Other Receivable PaymentOnOtherReceivable	296138	usd
	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	470040	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	162654	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-681409	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	21932	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	177534	usd
	NVOS	Repayments Of Finance Leases RepaymentsOfFinanceLeases	14797	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	4430794	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7327580	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	15270000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10802477	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7162046	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-20940	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	97970	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4384284	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6299327	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8293162	usd
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2067718	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12677446	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8367045	usd
	us-gaap	Interest Paid Net InterestPaidNet	1294912	usd
	us-gaap	Interest Paid Net InterestPaidNet	33183	usd
	NVOS	Common Stock Issued For Intangible Assets CommonStockIssuedForIntangibleAssets	188925	usd
	NVOS	Common Stock Issued For Intangible Assets CommonStockIssuedForIntangibleAssets	876000	usd
	NVOS	Common Stock Issued For Acquisition Of Assets CommonStockIssuedForAcquisitionOfAssets	1244550	usd
	NVOS	Common Stock Issued For Acquisition CommonStockIssuedForAcquisition	1704000	usd
	NVOS	Common Stock Issued For Acquisition CommonStockIssuedForAcquisition	430837	usd
	NVOS	Conversion Of Convertible Notes Payable And Accrued Interest To Common Stock ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock	1247849	usd
CY2021Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10 reverse stock split
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_846_eus-gaap--UseOfEstimates_zbCySsmPQoac" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zVt8CFHVCHn6">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. This applies in particular to useful lives of non-current assets, impairment of non-current assets, allowance for doubtful receivables, allowance for slow moving and obsolete inventory, and valuation allowance for deferred tax assets. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	705384	usd
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1097628	usd
CY2022Q2	NVOS	Allowance And Obsolete Inventory AllowanceAndObsoleteInventory	1065777	usd
CY2021Q3	NVOS	Allowance And Obsolete Inventory AllowanceAndObsoleteInventory	1066721	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zvU0QNcDjvsa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_860_zglwnzjL9fYd">Concentrations</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At May 31, 2022, one customer accounted for approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220529__20220531__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zeoeDcQZ51Jb" title="Concentration risk percentage">40</span>% of the accounts receivable balance. This same customer also accounted for approximately <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220301__20220531__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z5NvHUASt8K4"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220301__20220531__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zkp6NQzrTLQb">70</span></span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210901__20220531__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z1LEx827Gcqj"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210901__20220531__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zD0Uc6TgY8Ak">50</span></span>% of sales during the three and nine month periods ended May 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
CY2021	NVOS	Asset Impairment Charges Goodwill AssetImpairmentChargesGoodwill	99593	usd
CY2022Q2	us-gaap	Other Receivables OtherReceivables	1209137	usd
CY2021Q3	us-gaap	Other Receivables OtherReceivables	1506895	usd
CY2022Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1209137	usd
CY2021Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	814157	usd
CY2021Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	692738	usd
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1468429	usd
	NVOS	Schedule Of Intangible Assets Amortized Estimated Useful Lives ScheduleOfIntangibleAssetsAmortizedEstimatedUsefulLives	<p id="xdx_89B_ecustom--ScheduleOfIntangibleAssetsAmortizedEstimatedUsefulLives_zAGsV1PchO6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s intangible assets are being amortized over their estimated useful lives as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B3_zOXJKyEvhWB1" style="display: none">Schedule of Intangible Assets Amortized Estimated Useful Lives</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land use rights</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_pp0p0_dtY_c20210901__20220531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--LandUseRightsMember_zZeIILQxdE7j" title="Intangible assets, estimated lives">50</span> years (the lease period)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software license</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_pp0p0_dtY_c20210901__20220531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zMtrJqjQm6Ik" title="Intangible assets, estimated lives">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual property</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_pp0p0_dtY_c20210901__20220531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zfqX6AxRGHp7" title="Intangible assets, estimated lives">7</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer relationships</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_pp0p0_dtY_c20210901__20220531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zL71SbiSbnh" title="Intangible assets, estimated lives">5</span> years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand names</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_pp0p0_dtY_c20210901__20220531__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandNamesMember_zTDAEQYQS9Ck" title="Intangible assets, estimated lives">7</span> years</span></td></tr> </table>
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6070291	usd
	us-gaap	Depreciation Depreciation	408589	usd
	us-gaap	Depreciation Depreciation	57840	usd
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	8270812	shares
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	4308591	shares
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1015993	usd
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	991077	usd
CY2022Q2	NVOS	Allowance And Obsolete Inventory AllowanceAndObsoleteInventory	1065777	usd
CY2021Q3	NVOS	Allowance And Obsolete Inventory AllowanceAndObsoleteInventory	1066721	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	645063	usd
CY2021Q3	us-gaap	Inventory Net InventoryNet	339385	usd
CY2022Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	456528	usd
CY2021Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	478920	usd
CY2022Q2	NVOS	Trade Receivables TradeReceivables	5739193	usd
CY2021Q3	NVOS	Trade Receivables TradeReceivables	2411499	usd
CY2022Q2	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	132430	usd
CY2021Q3	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	154558	usd
CY2022Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	5871623	usd
CY2021Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	2566057	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	705384	usd
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1097628	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5166239	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1162067	usd
CY2021Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	1017566	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	144500	usd
CY2021Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	144628	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	404273	usd
CY2021Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	243912	usd
CY2022Q2	us-gaap	Inventory Gross InventoryGross	1710840	usd
CY2021Q3	us-gaap	Inventory Gross InventoryGross	1406106	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6986811	usd
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6716733	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1055128	usd
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	646442	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5931683	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	37091484	usd
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	34986108	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4898626	usd
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2956609	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	32192858	usd
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	32029499	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1940845	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1061085	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2690018	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2690018	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2690018	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2662926	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2115863	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	19344015	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	32192858	usd
CY2022Q2	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1023005	usd
CY2021Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	811660	usd
CY2022Q2	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	182231	usd
CY2021Q3	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	279018	usd
CY2022Q2	us-gaap	Deferred Revenue DeferredRevenue	38556	usd
CY2021Q3	us-gaap	Deferred Revenue DeferredRevenue	38631	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1243792	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1129309	usd
CY2022Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	5418701	usd
CY2021Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	9619253	usd
CY2022Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	5260056	usd
CY2021Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	4485649	usd
CY2022Q2	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	158645	usd
CY2021Q3	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	5133604	usd
	NVOS	Debt Instrument Interest Rate During Period Not Repay DebtInstrumentInterestRateDuringPeriodNotRepay	0.75	pure
CY2021Q4	NVOS	Original Issue Discount OriginalIssueDiscount	375000	usd
CY2021Q4	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	90000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	5260056	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	99822	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5343	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	5790	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	6244	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	41446	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	5418701	usd
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.05	pure
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5833334	shares
CY2022Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	2.00
	NVOS	Shares Adjustment Description SharesAdjustmentDescription	The warrants expire on December 14, 2025. The Company first determined the value of the $16.66m+ convertible notes and the fair value of the detachable warrants issued in connection with this transaction. The estimated value of the warrants of $7,680,156 was determined using the Black-Scholes option pricing model with the following assumptions
CY2022Q2	NVOS	Class Of Warrant Or Right Number Of Estimated Value Warrants Or Rights ClassOfWarrantOrRightNumberOfEstimatedValueWarrantsOrRights	7680156	usd
CY2022Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P4Y
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	16666666	usd
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	11409200	usd
CY2022Q2	NVOS	Discount On Convertable Note And Additional Paid In Capital DiscountOnConvertableNoteAndAdditionalPaidInCapital	5257466	usd
CY2022Q2	NVOS	Original Issue Discount OriginalIssueDiscount	1666666	usd
CY2022Q2	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	1140000	usd
CY2022Q2	NVOS	Debt Instrumentamortized Discount DebtInstrumentamortizedDiscount	2893927	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	5170205	usd
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.01	pure
CY2021Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-05-17
CY2021Q4	us-gaap	Share Price SharePrice	3.35
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	223880	shares
CY2021Q4	us-gaap	Share Price SharePrice	3.35
CY2021Q4	NVOS	Shares Adjustment Description SharesAdjustmentDescription	The warrants expire on November 17, 2024. The Company first determined the value of the $1.875m convertible notes and the fair value of the detachable warrants issued in connection with this transaction. The estimated value of the warrants of $351,240 and was determined using the Black-Scholes option pricing model with the following assumption
CY2021Q4	NVOS	Class Of Warrant Or Right Number Of Estimated Value Warrants Or Rights ClassOfWarrantOrRightNumberOfEstimatedValueWarrantsOrRights	351240	usd
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1875000	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1579176	usd
CY2021Q4	NVOS	Discount On Convertable Note And Additional Paid In Capital DiscountOnConvertableNoteAndAdditionalPaidInCapital	295824	usd
CY2021Q4	NVOS	Discount On Convertable Note And Additional Paid In Capital DiscountOnConvertableNoteAndAdditionalPaidInCapital	295824	usd
CY2020Q3	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	267768	usd
CY2022Q2	us-gaap	Secured Debt SecuredDebt	981337	usd
CY2021Q3	us-gaap	Secured Debt SecuredDebt	982205	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2222970	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2543396	usd
CY2022Q2	NVOS	Operating Lease Assets OperatingLeaseAssets	2222970	usd
CY2021Q3	NVOS	Operating Lease Assets OperatingLeaseAssets	2543396	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	544690	usd
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	530797	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1734790	usd
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2057805	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2279480	usd
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2588602	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	707309	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	491435	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	406221	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	379585	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	378902	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	464438	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2827890	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	548410	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2279480	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	544690	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1734790	usd
	us-gaap	Payments For Rent PaymentsForRent	567772	usd
	us-gaap	Payments For Rent PaymentsForRent	629029	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	556445	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	621228	usd
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M18D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2022Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.05	pure
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	209457	usd
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	209457	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	178383	usd
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	136491	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	31074	usd
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	72966	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	16631	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	8092	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	24723	usd
CY2022Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	178	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	24545	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	15982	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	8563	usd
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	499000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	the Company effected a 1-for-10 reverse stock split of our common stock. As a result of the reverse stock split, every 10 shares of issued and outstanding common stock were exchanged for one share of common stock, with any fractional shares being rounded up to the next higher whole share. At May 31, 2022 and August 31, 2021, there were 30,659,073 and 26,610,144 common shares issued and outstanding, respectively.
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30659073	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30659073	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26610144	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26610144	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1849600	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.29
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y1M20D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	218240	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	329985	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.41
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2179585	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.16
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term3 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3	P2Y8M26D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	658069	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1968096	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.25
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y6M7D
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	505797	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2179585	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1968096	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.37
CY2022Q2	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Option Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionWeightedAverageExercisePrice	1.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.76
CY2021Q2	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Option Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionWeightedAverageExercisePrice	3.80
	us-gaap	Share Based Compensation ShareBasedCompensation	289892	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	88855	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	273991	usd
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionExercisableWeightedAverageRemainingContractualTerm1	P3Y9M
CY2022Q2	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionExercisableIntrinsicValue1	291667	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1118925	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0042	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y6M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.81	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.68	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2388050	shares
CY2021Q3	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice	3.35
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionOutstandingWeightedAverageRemainingContractualTerm2	P5Y1M13D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	6057214	shares
	NVOS	Share Based Compensation Arrangements By Share Based Payment Award Non Option Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionGrantsInPeriodWeightedAverageExercisePrice	2.05
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	8445264	shares
CY2022Q2	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice	2.42
	NVOS	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Outstanding Weighted Average Remaining Contractual Term3 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionOutstandingWeightedAverageRemainingContractualTerm3	P3Y9M
CY2022Q2	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingIntrinsicValue	291667	usd
CY2022Q2	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisableNumber	8445264	shares
CY2022Q2	NVOS	Share Based Compensation Arrangement By Share Based Payment Award Non Option Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisableWeightedAverageExercisePrice	2.42
CY2021Q2	us-gaap	Gross Profit GrossProfit	1280458	usd
CY2021Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	200751	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	29291	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	42273	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	398	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	66759	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	1179361	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	189080	usd
CY2022Q2	NVOS	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Loan BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLoan	47766	usd
CY2022Q2	NVOS	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Minority Interest BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedMinorityInterest	97311	usd
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	983925	usd
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	983925	usd
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	983925	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13851883	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2380974	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19883033	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6612374	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	2408882	usd
	us-gaap	Gross Profit GrossProfit	4891702	usd
	us-gaap	Gross Profit GrossProfit	2843354	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1202746	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-401972	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4687081	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2485640	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	881597	usd
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	381502	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2349434	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	190973	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	201369	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	513398	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	21701	usd
	us-gaap	Interest Expense InterestExpense	1808310	usd
	us-gaap	Interest Expense InterestExpense	68590	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-3744025	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-415271	usd
	us-gaap	Profit Loss ProfitLoss	-10428624	usd
	us-gaap	Profit Loss ProfitLoss	-2528965	usd
CY2022Q2	us-gaap	Assets Assets	71792814	usd
CY2021Q3	us-gaap	Assets Assets	61958281	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5166239	usd
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1468429	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	32192858	usd
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	32029499	usd
CY2022Q2	us-gaap	Goodwill Goodwill	11366618	usd
CY2021Q3	us-gaap	Goodwill Goodwill	9488848	usd

Files In Submission

Name	View Source	Status
0001493152-22-019313-index-headers.html	Edgar Link	pending
0001493152-22-019313-index.html	Edgar Link	pending
0001493152-22-019313.txt	Edgar Link	pending
0001493152-22-019313-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
nvos-20220531.xsd	Edgar Link	pending
nvos-20220531_cal.xml	Edgar Link	unprocessable
nvos-20220531_def.xml	Edgar Link	unprocessable
nvos-20220531_lab.xml	Edgar Link	unprocessable
nvos-20220531_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVOS
Novo Integrated Sciences, Inc. Stock $nvos

2022 Q3 Form 10-Q Financial Statement

#000149315222019313 Filed on July 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVOS Novo Integrated Sciences, Inc. Stock $nvos

2022 Q3 Form 10-Q Financial Statement

#000149315222019313 Filed on July 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVOS
Novo Integrated Sciences, Inc. Stock $nvos